Genome-wide association studies (GWAS) in migraine are providing the molecular basis
of this heterogeneous disease, but the understanding of its aetiology is still
incomplete. Although some biomarkers have currently been accepted for migraine, large
amount of studies for identifying new ones is needed. The migraine-associated variant
rs12355831:A>G (P=2 Ă 10â6), described in a
GWAS of the International Headache Genetic Consortium, is localized in a non-coding
sequence with unknown function. We sought to identify the causal variant and the
genetic mechanism involved in the migraine risk. To this end, we integrated data of
RNA sequences from the Genetic European Variation in Health and Disease (GEUVADIS)
and genotypes from 1000 GENOMES of 344 lymphoblastoid cell lines (LCLs), to determine
the expression quantitative trait loci (eQTLs) in the region. We found that the
migraine-associated variant belongs to a linkage disequilibrium block associated with
the expression of an acyl-coenzyme A synthetase 5 (ACSL5) transcript lacking exon 20
(ACSL5-Î20). We showed by exon-skipping assay a direct causality of rs2256368-G
in the exon 20 skipping of approximately 20 to 40% of ACSL5 RNA molecules. In
conclusion, we identified the functional variant (rs2256368:A>G) affecting ACSL5
exon 20 skipping, as a causal factor linked to the migraine-associated
rs12355831:A>G, suggesting that the activation of long-chain fatty acids by the
spliced ACSL5-Î20 molecules, a mitochondrial located enzyme, is involved in
migraine pathology.